Filter
69
Filtered Results: 69
Text search:
Sputnik
V
Featured
Recommendations
4
New Publications
1
Language
Document type
Studies & Reports
16
Guidelines
14
Fact sheets
14
No document type
9
Resource Platforms
5
Manuals
4
Situation Updates
3
Strategic & Response Plan
3
Infographics
1
Countries / Regions
Argentina
10
Ukraine
6
Chile
4
Paraguay
4
Russia
4
Africa
3
Latin America and the Carribbean
3
Germany
3
Brazil
3
Syria
2
Western and Central Europe
2
India
2
Kenya
1
Ghana
1
Congo-Brazzaville
1
Mozambique
1
Guinea-Bissau
1
West and Central Africa
1
South–East Asia Region
1
Eastern Europe and Central Asia
1
Belarus
1
East and Southern Africa
1
Angola
1
Authors & Publishers
Publication Years
Category
COVID-19
40
Guidelines
9
Studies & Reports
7
Women & Child Health
3
Information, Education and Communication (IEC)
2
Hepatitis
1
Pediatrics
1
Policies
1
Humanitarian Crisis
1
Pharmacy & Technologies
1
Toolboxes
Country specific documents
26
Immunization Guidelines
5
TB & Drug Abuse
4
Global Impact: Socio-economic, health services, TB & HIV
3
Communication Material
3
Vaccine Hesitancy & Myths
3
Biontech/Pfizer Comirnaty
3
Johnson & Johnson
3
Sputnik V
3
Information Refugees Ukraine
3
Poster & Infographics
2
For General Public & Community
2
Scientific & Research Studies
2
Country-specific Platforms
2
Dashboards & Resource Platforms
2
Fair Allocation & Ethical Aspects
2
Moderna
2
Vaxzevria (Astra Zeneca)
2
Estonia
2
Booster Doses
2
Integration
1
Vaccination
1
Ukraine
1
Pediatrics
1
Germany
1
Clinical Guidelines
1
General
1
COVID-19
1
For Parents & Children
1
For Pregnant Women
1
Dashboards & Maps
1
Paediatrics
1
HIV and COVID-19
1
Hospital Readiness/Essential Health Services
1
Vaccination & Strategy
1
Access & Strategy
1
COVID-19 Vaccination
1
Research & Pipeline
1
Inactivated COVID-19 Vaccines
1
Essential Medicines
1
Prices and Patents
1
Situation Reports & Updates
1
Information, Resources & Websites
1
COVID-19
1
Global Overview
1
Situation Reports & Updates
1
Human Rights & the Right to Health
1
Miscellaneous
1
Public Health Administration
1
Orientation Guides
1
Refugees & Migrants
1
Volunteers
1
Country Specific Information
1
Reports & Studies
1
Eastern Europe and central Asia
1
This website has been created to provide accurate and up-to-date information about Sputnik V.
It will be updated continuously.
Details of COVID-19 availability in all ten ASEAN countries and another 30 Asian nations.
Due to the developing situation in China and Asia concerning the Coronavirus, we will be operating this article as a running live update service to keep businesses involved in...
Published:February 02, 2021DOI:https://doi.org/10.1016/S0140-6736(21)00234-8
7 June 2021
The Africa Regulatory Taskforce is a joint effort established by the Africa Centres for Disease Control and Prevention (Africa CDC), the African Union Development Agency (AUDA-NEPAD) coordinated African Medicines Regulatory Harmonization (AMRH) Initiative, and the World Health Organisat...
Bisher hat die STIKO empfohlen, dass alle im Ausland mit einem nicht in der EU zugelassenen Impfstoff geimpften Personen eine erneute Impfserie mit einem in der EU zugelassenen Impfstoff erhalten sollen. Ziel der im Epidemiologischen Bulletin 13/2022 veröffentlichten aktualisierten COVID-19-Impfemp...
Available in different languages
Position paper on vaccination with Sputnik V vaccine | National Commission on Vaccine Safety (CoNaSeVa) | 12 May 2021
Vaccinator's Manual SINOPHARM Vaccine - 28 FEBRUARY 2021
Frequently asked questions on COVID-19 vaccination. Version 6, 12 February 2022
En Paraguay, la vacunación contra COVID-19 inició el 22 de febrero de 2021. Se han autorizado un total de siete vacunas: Bharat-Covaxin, Moderna, Pfizer-BioNTech, AstraZeneca, Sinopharm, Sputnik V- Gamaleya y CoronaVac-Sinovac. Los grupos prioritarios de vacunación están definidos según el Plan...
As vacinas COVID-19 são eficazes contra novas variantes? O que significa para uma pessoa estar totalmente vacinada? Essa e outras dúvidas estão entre as dúvidas mais frequentes sobre a vacinação contra a COVID-19. Nesta sexta edição você encontrará respostas para essas e outras perguntas.
...
Campaña Nacional de Vacunación contra la COVID-19
La dosis de refuerzo está indicada una vez transcurridos los 4 meses (120 días) de la última dosis del esquema inicial y será con vacuna de plataforma ARNm: Pfizer-BioNTech pediátrica a partir de los 5 años o Moderna para uso pediátrico a partir de los 6 años.
La evidencia disponible a nivel internacional sobre el uso de un segundo refuerzo muestra una mayor duración de la respuesta inmune y una disminución de la internación y la mortalidad por COVID 19 en la población de adultos mayores y huéspedes inmunocomprometidos. Por otra parte, el personal de...
Los datos preliminares de eficacia se infirieron mediante un enfoque de “inmunogenicidad puente”, en el que los títulos neutralizantes obtenidos después de la vacuna en niños y niñas de 5 a 11 años se compararon con los títulos obtenidos en adolescentes de 16 a 25 años (en quienes se hab...
El siguiente manual se continuará actualizando, de ser necesario, a medida que se disponga de nueva información.
